Search Results - bolormaa+baljinnyam

3 Results Sort By:
GazePair: Mixed Reality Device Pairing
THE CHALLENGE The Global Augmented Reality (AR) market was recently estimated to be just under $15 billion, and is expected to grow by nearly 600% by 2026. As this market continues to grow and AR devices become ubiquitous, the need for quick, efficient, and secure methods for pairing these devices will become vital. Most pairing methods currently in...
Published: 12/8/2023   |   Inventor(s): Bo Ji, Matthew Corbett, Jiacheng Shang
Keywords(s):  
Category(s): Technology Classifications > Computer Science, Technology Classifications > Communication, Technology Classifications > Security
BystandAR: Protecting Bystander Visual Data Privacy in Augmented Reality Systems
THE CHALLENGE Well-intentioned AR users often unknowingly violate bystander privacy by collecting and sharing sensitive data. Some apps use machine learning to make inferences without user knowledge, further compromising privacy. The current permissions within the state of the art are flawed as colluding apps deceive users to access and share data...
Published: 10/2/2024   |   Inventor(s): Matthew Corbett, Brendan David-John, Bo Ji, Jiacheng Shang, Charlie Hu
Keywords(s):  
Category(s): Technology Classifications > Computer Science, Technology Classifications > Communication, Technology Classifications > Security
CD206 Small Molecule Modulators, Their Use and Methods for Preparation
Abstract: Pancreatic ductal adenocarcinoma (PDA) accounts for more than 90% of pancreatic cancer cases, and it is one of the most aggressive malignancies with a 5-year survival rate of 6%. The high mortality rate caused by PDA is primarily from the lack of early diagnosis – it is often asymptomatic in early stages – and a poor response to conventional...
Published: 4/8/2024   |   Inventor(s): Udo Rudloff, Juan Marugan, Xin Hu, Raul Calvo, Noel Southall, Bolormaa Baljinnyam
Keywords(s): CD206, M1 Macrophage, M2 Macrophage, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDA, Rudloff, TAM, Tumor-Associated Macrophages
Category(s): Collaboration Sought > Licensing, Application > Therapeutics, TherapeuticArea > Oncology, Collaboration Sought > Collaboration